Published on 14 Oct 2022 on Market Watch
Shares of Corbus Pharmaceuticals Holdings Inc. soared 20.55% to $0.13 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.23% to 10,649.15 and the Dow Jones Industrial Average rising 2.83% to 30,038.72. The stock's rise snapped a four-day losing streak. Corbus Pharmaceuticals Holdings Inc. closed $0.98 short of its 52-week high ($1.11), which the company reached on November 16th.
The stock outperformed some of its competitors Thursday, as Fate Therapeutics Inc. rose 0.56% to $21.45, Vanda Pharmaceuticals Inc. rose 2.57% to $9.96, and Viking Therapeutics Inc. rose 4.95% to $3.18. Trading volume (21.9 M) eclipsed its 50-day average volume of 1.3 M.